Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 11 open reading frame 68 (C11orf68) is an RNA-binding protein that has been implicated in the invasiveness and metastasis of various cancer types, including breast, liver, and prostate cancer. Epigenetic studies have demonstrated that upregulation of this gene is part of a hypomethylation signature distinguishing invasive cancer cells, and knockdown of C11orf68 reduces cellular invasion, suggesting it could be a promising therapeutic target in cancer. However, its normal biological function remains poorly characterized and is under continued investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 11 open reading frame 68 (C11orf68).